These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 13520425

  • 1. [Sulfonamide inhibitors of tubular function, carbonic anhydrase inhibitors & hypoglycemics].
    HAZARD R, PIGNARD P.
    Actual Pharmacol (Paris); 1957; 10():175-237. PubMed ID: 13520425
    [No Abstract] [Full Text] [Related]

  • 2. The vasodilating effect of acetazolamide and dorzolamide involves mechanisms other than carbonic anhydrase inhibition.
    Torring MS, Holmgaard K, Hessellund A, Aalkjaer C, Bek T.
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):345-51. PubMed ID: 18757514
    [Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action?
    Krungkrai J, Scozzafava A, Reungprapavut S, Krungkrai SR, Rattanajak R, Kamchonwongpaisan S, Supuran CT.
    Bioorg Med Chem; 2005 Jan 17; 13(2):483-9. PubMed ID: 15598570
    [Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
    Innocenti A, Firnges MA, Antel J, Wurl M, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Feb 15; 15(4):1149-54. PubMed ID: 15686931
    [Abstract] [Full Text] [Related]

  • 5. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II.
    Menchise V, De Simone G, Di Fiore A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2006 Dec 15; 16(24):6204-8. PubMed ID: 17000110
    [Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I, Minakuchi T, Kohsaki T, Onishi S, Takeuchi H, Vullo D, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2007 Jul 01; 17(13):3585-94. PubMed ID: 17482815
    [Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
    Nishimori I, Minakuchi T, Morimoto K, Sano S, Onishi S, Takeuchi H, Vullo D, Scozzafava A, Supuran CT.
    J Med Chem; 2006 Mar 23; 49(6):2117-26. PubMed ID: 16539401
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX.
    Turkmen H, Durgun M, Yilmaztekin S, Emul M, Innocenti A, Vullo D, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 Jan 17; 15(2):367-72. PubMed ID: 15603956
    [Abstract] [Full Text] [Related]

  • 9. Carbonic anhydrase inhibitors: thioxolone versus sulfonamides for obtaining isozyme-selective inhibitors?
    Innocenti A, Maresca A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):3938-41. PubMed ID: 18572406
    [Abstract] [Full Text] [Related]

  • 10. Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.
    Nishimori I, Vullo D, Minakuchi T, Morimoto K, Onishi S, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2006 Apr 15; 16(8):2182-8. PubMed ID: 16459077
    [Abstract] [Full Text] [Related]

  • 11. Quaternary ammonium substituted thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxides: Potential membrane-impermeable inhibitors of carbonic anhydrase.
    May JA, Namil A, Chen HH, Dantanarayana AP, Dupré B, Liao JC.
    Bioorg Med Chem; 2006 Mar 15; 14(6):2052-9. PubMed ID: 16297631
    [Abstract] [Full Text] [Related]

  • 12. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.
    Vullo D, Franchi M, Gallori E, Antel J, Scozzafava A, Supuran CT.
    J Med Chem; 2004 Feb 26; 47(5):1272-9. PubMed ID: 14971907
    [Abstract] [Full Text] [Related]

  • 13. Variable involvement of the perivascular retinal tissue in carbonic anhydrase inhibitor induced relaxation of porcine retinal arterioles in vitro.
    Kehler AK, Holmgaard K, Hessellund A, Aalkjaer C, Bek T.
    Invest Ophthalmol Vis Sci; 2007 Oct 26; 48(10):4688-93. PubMed ID: 17898293
    [Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.
    Zimmerman S, Innocenti A, Casini A, Ferry JG, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Dec 20; 14(24):6001-6. PubMed ID: 15546717
    [Abstract] [Full Text] [Related]

  • 15. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
    Winum JY, Thiry A, Cheikh KE, Dogné JM, Montero JL, Vullo D, Scozzafava A, Masereel B, Supuran CT.
    Bioorg Med Chem Lett; 2007 May 15; 17(10):2685-91. PubMed ID: 17376683
    [Abstract] [Full Text] [Related]

  • 16. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT.
    J Med Chem; 2005 Dec 01; 48(24):7860-6. PubMed ID: 16302824
    [Abstract] [Full Text] [Related]

  • 17. Effects of the selective cyclooxygenase-2 inhibitor analgesic celecoxib on renal carbonic anhydrase enzyme activity: a randomized, controlled trial.
    Alper AB, Tomlin H, Sadhwani U, Whelton A, Puschett J.
    Am J Ther; 2006 Dec 01; 13(3):229-35. PubMed ID: 16772765
    [Abstract] [Full Text] [Related]

  • 18. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
    Güzel O, Innocenti A, Scozzafava A, Salman A, Supuran CT.
    Bioorg Med Chem; 2009 Jul 15; 17(14):4894-9. PubMed ID: 19539481
    [Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I, Minakuchi T, Onishi S, Vullo D, Scozzafava A, Supuran CT.
    J Med Chem; 2007 Jan 25; 50(2):381-8. PubMed ID: 17228881
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
    Lehtonen JM, Parkkila S, Vullo D, Casini A, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2004 Jul 16; 14(14):3757-62. PubMed ID: 15203157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.